OCPH Stock Overview
October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
October Pharma S.A.E Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م100.00 |
| 52 Week High | ج.م110.00 |
| 52 Week Low | ج.م80.00 |
| Beta | -0.20 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | 100.00% |
| 5 Year Change | 177.09% |
| Change since IPO | 2,005.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| OCPH | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | 0% | -7.8% | -11.5% |
| 1Y | 0% | 27.3% | 47.9% |
Return vs Industry: OCPH underperformed the EG Pharmaceuticals industry which returned 28.2% over the past year.
Return vs Market: OCPH underperformed the EG Market which returned 52.8% over the past year.
Price Volatility
| OCPH volatility | |
|---|---|
| OCPH Average Weekly Movement | 0% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in EG Market | 13.3% |
| 10% least volatile stocks in EG Market | 4.7% |
Stable Share Price: OCPH has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine OCPH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | n/a | www.octoberpharma.com |
October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides its products in solid forms, such as tablets, capsules, and powders; liquid forms comprising syrups, drops, solutions, and sprays; creams and suppositories; soft gelatin capsules; and ampoules and vials. October Pharma S.A.E was founded in 1987 is based in Cairo, Egypt.
October Pharma S.A.E Fundamentals Summary
| OCPH fundamental statistics | |
|---|---|
| Market cap | ج.م1.20b |
| Earnings (TTM) | ج.م150.40m |
| Revenue (TTM) | ج.م1.01b |
8.0x
P/E Ratio1.2x
P/S RatioIs OCPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OCPH income statement (TTM) | |
|---|---|
| Revenue | ج.م1.01b |
| Cost of Revenue | ج.م515.09m |
| Gross Profit | ج.م496.56m |
| Other Expenses | ج.م346.16m |
| Earnings | ج.م150.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 12.53 |
| Gross Margin | 49.08% |
| Net Profit Margin | 14.87% |
| Debt/Equity Ratio | 54.9% |
How did OCPH perform over the long term?
See historical performance and comparison